We would like to introduce to the readership an exciting new section in this issue of the Indian Journal of Ophthalmology, entitled "One Minute Ophthalmology." This segment will be incorporated into each upcoming issue of the journal, designed to teach the reader an important point in approximately 1 minute using a problem-solving, case-based questions and discussion approach. It will instill critical thinking to solve a case with clinical reasoning and analysis. This section is designed to encourage the reader to think "What would I do in this case?" and then choose the most appropriate alternative. This promises to be stimulating, challenging, and instructive. We welcome the readership to consider submission of a case, common or rare, to this section at the journal website at \<http://www.journalonweb.com/ijo\>.

The goal of this new feature is to hone our clinical skills to be razor sharp.

One-minute ophthalmology (OMO), exactly as the name indicates, is to teach a valuable ophthalmic point in 1 minute. This new addition to the journal will be in a single page, concise case report format, and divided into short mini segments. These mini segments include word count-limited components so that the case fits neatly on one page as follows:

Title -- Clinical title without revealing the diagnosisCase -- Description limited to ≤100 wordsWhat is your next step? -- Listing four choices as A, B, C, and D and limited to ≤50 wordsIllustration -- Limited to ≤4 images, preferably in neat montage arrangement, tiff format, 300 dots per inchFindings -- Information regarding imaging, blood testing, histopathology, or others, limited to ≤100 wordsDiagnosis -- Listed in ≤5 wordsCorrect answer -- Listed by the correct letter A, B, C, and D, as indicated in What is your next step?Discussion -- Description of disease in ≤100 wordsReferences -- Limited to ≤3Authors and affiliations -- Limited to ≤3 authors. List affiliations.

We encourage you to take time to read the first OMO case in this issue of the Indian Journal of Ophthalmology. Challenge your skills. Solve the riddle. See if you would manage the patient as suggested by the authors.

Going forward, we welcome readers of the journal to think of their best-instructive case and submit to the journal at \<<http://www.journalonweb.com/ijo>\> for peer review. Together we spend just a minute, share an enlightening case, learn from each other, and polish our clinical acumen, to walk away with greater knowledge -- as a more-clever ophthalmologist.
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